Princeton Portfolio Strategies Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,370
Closed -$212K 160
2018
Q3
$212K Sell
2,370
-3,490
-60% -$308K 0.06% 150
2018
Q2
$465K Sell
5,860
-8,477
-59% -$704K 0.13% 124
2018
Q1
$1.28M Sell
14,337
-2,365
-14% -$227K 0.36% 77
2017
Q4
$1.74M Sell
16,702
-6,125
-27% -$691K 0.48% 64
2017
Q3
$3.33M Sell
22,827
-100
-0.4% -$13.6K 0.9% 40
2017
Q2
$2.98M Sell
22,927
-265
-1% -$32.5K 0.85% 40
2017
Q1
$2.89M Sell
23,192
-215
-0.9% -$25.7K 0.86% 38
2016
Q4
$2.71M Sell
23,407
-300
-1% -$33.4K 0.85% 41
2016
Q3
$2.48M Sell
23,707
-200
-0.8% -$21.6K 0.78% 46
2016
Q2
$2.36M Buy
23,907
+4,821
+25% +$499K 0.76% 49
2016
Q1
$1.91M Sell
19,086
-1,695
-8% -$175K 0.65% 51
2015
Q4
$2.49M Buy
20,781
+1,725
+9% +$200K 0.88% 41
2015
Q3
$2.06M Buy
19,056
+50
+0.3% +$6.21K 0.84% 45
2015
Q2
$2.2M Buy
19,006
+50
+0.3% +$5.72K 0.77% 48
2015
Q1
$2.19M Buy
18,956
+70
+0.4% +$8.37K 0.84% 47
2014
Q4
$2.11M Buy
18,886
+300
+2% +$31.6K 0.84% 49
2014
Q3
$1.76M Buy
18,586
+790
+4% +$71.3K 0.74% 55
2014
Q2
$1.53M Buy
17,796
+2,296
+15% +$175K 0.66% 59
2014
Q1
$1.08M Sell
15,500
-560
-3% -$44.3K 0.72% 49
2013
Q4
$1.36M Buy
16,060
+260
+2% +$20.6K 0.91% 38
2013
Q3
$1.22M Buy
15,800
+3,186
+25% +$223K 0.9% 42
2013
Q2
$738K Buy
+12,614
New +$759K 0.6% 60

Other funds holding CELG

Princeton Portfolio Strategies Group's CELG Position: Q4 2018 in Review

Princeton Portfolio Strategies Group sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 2,370 shares — an estimated $212K sold.

Princeton Portfolio Strategies Group first reported a position in CELG in Q2 2013 and held it in 22 quarters. The position peaked at $3.33M in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Princeton Portfolio Strategies Group reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Princeton Portfolio Strategies Group sold 2,370 Celgene Corp shares in Q4 2018, an estimated $212K.
  • Princeton Portfolio Strategies Group first reported a position in Celgene Corp in Q2 2013 and held it in 22 quarters.
  • Princeton Portfolio Strategies Group's Celgene Corp position peaked at $3.33M in Q3 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Princeton Portfolio Strategies Group's 13F filing for Q4 2018, filed 13 Feb 2019.